One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Including African data in drug discovery and development
Clinton G. L. VealeAdrienne L. EdkinsKelly Chibale
doi : 10.1038/d41573-023-00088-8
Volume 22 Issue 7, July 2023
FDA approves first-in-class NK3 receptor antagonist for hot flushes
Asher Mullard
PD1 agonist antibody passes first phase II trial for autoimmune disease
Asher Mullard
FDA approves new antibiotic combination for drug-resistant pneumonia
Asher Mullard
First-in-class versus best-in-class: an update for new market dynamics
Lindsay Spring, Kunle Demuren, Michael Ringel & John Wu
A ROS-mediated resistance pathway to anticancer drugs
Alex Eccleston
Improving leukaemia treatment with bispecific antibodies
Sarah Crunkhorn
Amplifying gene expression with RNA-targeted therapeutics
Olga Khorkova, Jack Stahl, Aswathy Joji, Claude-Henry Volmar & Claes WahlestedtÂ
Deuterium in drug discovery: progress, opportunities and challenges
Rita Maria Concetta Di Martino, Brad D. Maxwell & Tracey PiraliÂ
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, Lisa A. Purcell, Kumar Singh Saikatendu, Uli Schmitz, John A. Tallarico & Alpha A. LeeÂ
